Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0025362 (
mental retardation
)
15,878
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Robert syndrome (RBS) and Cornelia de Lange syndrome (CdLS) are human developmental disorders characterized by craniofacial deformities, limb malformation and
mental retardation
. These birth defects are collectively termed cohesinopathies as both arise from mutations in cohesion genes. CdLS arises due to autosomal dominant mutations or haploinsufficiencies in cohesin subunits (
SMC1A
,
SMC3
and
RAD21
) or cohesin auxiliary factors (
NIPBL
and
HDAC8
) that result in transcriptional dysregulation of developmental programs. RBS arises due to autosomal recessive mutations in cohesin auxiliary factor
ESCO2
, the gene that encodes an N-acetyltransferase which targets the
SMC3
subunit of the cohesin complex. The mechanism that underlies RBS, however, remains unknown. A popular model states that RBS arises due to mitotic failure and loss of progenitor stem cells through apoptosis. Previous findings in the zebrafish regenerating fin, however, suggest that Esco2
-
knockdown results in transcription dysregulation, independent of apoptosis, similar to that observed in CdLS patients. Previously, we used the clinically relevant
CX43
to demonstrate a transcriptional role for Esco2.
CX43
is a gap junction gene conserved among all vertebrates that is required for direct cell-cell communication between adjacent cells such that
cx43
mutations result in oculodentodigital dysplasia. Here, we show that morpholino-mediated knockdown of
smc3
reduces
cx43
expression and perturbs zebrafish bone and tissue regeneration similar to those previously reported for
esco2
knockdown. Also similar to Esco2-dependent phenotypes, Smc3-dependent bone and tissue regeneration defects are rescued by transgenic Cx43 overexpression, suggesting that Smc3 and Esco2 cooperatively act to regulate cx43 transcription. In support of this model, chromatin immunoprecipitation assays reveal that Smc3 binds to a discrete region of the
cx43
promoter, suggesting that Esco2 exerts transcriptional regulation of
cx43
through modification of Smc3 bound to the
cx43
promoter. These findings have the potential to unify RBS and CdLS as transcription-based mechanisms.
...
PMID:Cohesin mediates Esco2-dependent transcriptional regulation in a zebrafish regenerating fin model of Roberts Syndrome. 2908 13
Cornelia de Lange syndrome (CdLS) is a rare autosomal-dominant genetic disorder characterised by prenatal and postnatal growth and
mental retardation
, facial dysmorphism and upper limb abnormalities. Germline mutations of cohesin complex genes
SMC1A
,
SMC3
,
RAD21
or their regulators
NIPBL
and
HDAC8
have been identified in CdLS as well as somatic mutations in myeloid disorders. We describe the first case of a paediatric patient with CdLS with B-cell precursor Acute Lymphoblastic Leukaemia (ALL). The patient did not show any unusual cytogenetic abnormality, and he was enrolled into the high risk arm of AIEOP-BFM ALL2009 protocol because of slow early response, but 3 years after discontinuation, he experienced an ALL relapse. We identified a heterozygous mutation in exon 46 of
NIPBL
, causing frameshift and a premature stop codon (RNA-Targeted Next generation Sequencing Analysis). The analysis of the family indicated a de novo origin of this previously not reported deleterious variant. As for somatic cohesin mutations in acute myeloid leukaemia, also this ALL case was not affected by aneuploidy, thus suggesting a major impact of the non-canonical role of
NIPBL
in gene regulation. A potential biological role of
NIPBL
in leukaemia has still to be dissected.
...
PMID:First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia. 3094 35
<< Previous
1
2